# Klotho Neurosciences Inc. (KLTO)

Source: https://www.quantisnow.com/company/KLTO
Generated: 2026-11-14T03:14:18.068Z

- Ticker: KLTO
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2022

## Latest KLTO news and filings

- 2026-05-21 15:21 UTC [Why a $35 Million Greenland Rare Earth Deal Just Put One Small-Cap on Every Investor's Radar](https://www.quantisnow.com/insight/why-a-35-million-greenland-rare-earth-deal-just-put-6566807)
- 2026-03-16 16:32 UTC [SEC Form 8-K] [Klotho Neurosciences Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/klotho-neurosciences-inc-filed-sec-form-8-k-amendments-to-articles-6448879)
- 2026-03-12 20:00 UTC [SEC Form 8-K] [Klotho Neurosciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/klotho-neurosciences-inc-filed-sec-form-8-k-regulation-fd-disclosure-6444247)
- 2026-03-12 14:27 UTC [Leadership Update] [Klotho Neurosciences Completes Rebranding to Greenland Mines Ltd and Change of Nasdaq Ticker Symbol to GRML](https://www.quantisnow.com/insight/klotho-neurosciences-completes-rebranding-to-greenland-mines-ltd-and-change-6443949)
- 2026-03-10 21:00 UTC [SEC Form 8-K] [Klotho Neurosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/klotho-neurosciences-inc-filed-sec-form-8-k-entry-into-a-6440171)
- 2026-03-09 12:30 UTC [Leadership Update] [Klotho Neurosciences Announces Rebranding to Greenland Mines Ltd and Change of Nasdaq Ticker Symbol to GRML Effective March 12, 2026](https://www.quantisnow.com/insight/klotho-neurosciences-announces-rebranding-to-greenland-mines-ltd-and-change-6436397)
- 2026-03-06 21:12 UTC [SEC Form 4] [Chief Financial Officer Leblanc Jeff was granted 2,500,000 shares, increasing direct ownership by 272% to 3,420,342 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-leblanc-jeff-was-granted-2500000-shares-increasing-6434910)
- 2026-03-06 21:02 UTC [SEC Form 4] [Director El-Dada Riad Hussein was granted 350,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-el-dada-riad-hussein-was-granted-350000-shares-sec-form-6434720)
- 2026-03-06 20:58 UTC [SEC Form 4] [Director Zentman Samuel M was granted 350,000 shares, increasing direct ownership by 48% to 1,086,440 units (SEC Form 4)](https://www.quantisnow.com/insight/director-zentman-samuel-m-was-granted-350000-shares-increasing-direct-6434656)
- 2026-03-06 20:50 UTC [SEC Form 4] [Director Hirschman Shalom was granted 350,000 shares, increasing direct ownership by 63% to 908,873 units (SEC Form 4)](https://www.quantisnow.com/insight/director-hirschman-shalom-was-granted-350000-shares-increasing-direct-ownership-6434649)
- 2026-03-06 20:25 UTC [SEC Form 4] [Director Mcgarity Jon was granted 350,000 shares, increasing direct ownership by 571% to 411,277 units (SEC Form 4)](https://www.quantisnow.com/insight/director-mcgarity-jon-was-granted-350000-shares-increasing-direct-ownership-6434631)
- 2026-03-06 20:11 UTC [SEC Form 4] [Chief Executive Officer Sinkule Joseph was granted 2,500,000 shares, increasing direct ownership by 65% to 6,346,700 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-sinkule-joseph-was-granted-2500000-shares-increasing-6434617)
- 2026-03-04 21:30 UTC [SEC Form 8-K] [Klotho Neurosciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/klotho-neurosciences-inc-filed-sec-form-8-k-regulation-fd-disclosure-6429825)
- 2026-03-04 13:00 UTC [Mergers & Acquisitions] [KLOTHO NEUROSCIENCES ACQUIRES GREENLAND MINES CORP., SECURING CONTROL OF A $68 BILLION PALLADIUM, GOLD, PLATINUM, AND CRITICAL MINERAL DEPOSIT IN THE WORLD'S MOST STRATEGICALLY VITAL EMERGING TRADE CORRIDOR](https://www.quantisnow.com/insight/klotho-neurosciences-acquires-greenland-mines-corp-securing-control-of-a-6428425)
- 2026-03-02 22:03 UTC [SEC Form 8-K] [Klotho Neurosciences Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities](https://www.quantisnow.com/insight/klotho-neurosciences-inc-filed-sec-form-8-k-unregistered-sales-of-6422672)
- 2026-02-24 13:00 UTC [Klotho Neurosciences (NASDAQ:KLTO) Initiates Development of the "Klotho Clock," a Diagnostic Biological Aging and Longevity Clock that Unlocks Health Testing Through Epigenetics and Artificial Intelligence (AI)](https://www.quantisnow.com/insight/klotho-neurosciences-nasdaqklto-initiates-development-of-the-klotho-clock-a-6408960)
- 2026-02-24 11:12 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Klotho Neurosciences Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-klotho-neurosciences-inc-6408561)
- 2026-02-18 13:00 UTC [Klotho Neurosciences Receives Patent Claims in Australia for Composition and Use of Human Secreted Klotho Protein ("s-KL") Isoform of the Human Klotho Gene Sequence](https://www.quantisnow.com/insight/klotho-neurosciences-receives-patent-claims-in-australia-for-composition-and-6398333)
- 2026-02-17 22:20 UTC [SEC Form 8-K] [Klotho Neurosciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/klotho-neurosciences-inc-filed-sec-form-8-k-submission-of-matters-6397145)
- 2026-01-26 22:27 UTC [SEC Form DEFR14A filed by Klotho Neurosciences Inc.](https://www.quantisnow.com/insight/sec-form-defr14a-filed-by-klotho-neurosciences-inc-6361071)
- 2026-01-23 22:23 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Klotho Neurosciences Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-klotho-neurosciences-inc-6359618)
- 2026-01-12 20:48 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Klotho Neurosciences Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-klotho-neurosciences-inc-6346256)
- 2026-01-08 13:00 UTC [Conference Announcement] [Klotho Neurosciences to Present at the Biotech Showcase 2026](https://www.quantisnow.com/insight/klotho-neurosciences-to-present-at-the-biotech-showcase-2026-6342258)
- 2025-12-15 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Klotho Neurosciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-klotho-neurosciences-inc-6315103)
- 2025-12-10 18:49 UTC [SEC Form 4] [SEC Form 4 filed by Director Mcgarity Jon](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-mcgarity-jon-6310355)
- 2025-12-10 18:46 UTC [SEC Form 4] [SEC Form 4 filed by Director Zentman Samuel M](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-zentman-samuel-m-6310350)
- 2025-12-10 18:38 UTC [SEC Form 4] [SEC Form 4 filed by Director El-Dada Riad Hussein](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-el-dada-riad-hussein-6310341)
- 2025-12-08 21:31 UTC [SEC Form 8-K] [Klotho Neurosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/klotho-neurosciences-inc-filed-sec-form-8-k-entry-into-a-6307218)
- 2025-12-05 22:17 UTC [SEC Form S-1] [SEC Form S-1 filed by Klotho Neurosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-1-filed-by-klotho-neurosciences-inc-6305486)
- 2025-11-13 20:14 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Klotho Neurosciences Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-klotho-neurosciences-inc-6277077)
- 2025-11-07 15:03 UTC [Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award](https://www.quantisnow.com/insight/klotho-neurosciences-wins-the-2025-biotech-breakthrough-cell-therapy-innovation-6267630)
- 2025-11-06 19:45 UTC [SEC Form S-8] [SEC Form S-8 filed by Klotho Neurosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-klotho-neurosciences-inc-6264965)
- 2025-10-16 12:00 UTC [Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston](https://www.quantisnow.com/insight/klotho-neurosciences-ceo-to-attend-longevity-biotech-2025-in-boston-6234979)
- 2025-10-07 22:20 UTC [Klotho Neurosciences Announces Expiration of Letter of Intent](https://www.quantisnow.com/insight/klotho-neurosciences-announces-expiration-of-letter-of-intent-6226715)
- 2025-09-30 19:58 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Klotho Neurosciences Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-klotho-neurosciences-inc-6215930)
- 2025-09-30 12:30 UTC [Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership](https://www.quantisnow.com/insight/klotho-neurosciences-signs-letter-of-intent-to-acquire-select-assets-6215439)
- 2025-09-29 18:37 UTC [SEC Form 4] [Chief Executive Officer Sinkule Joseph acquired 400,000 shares, increasing direct ownership by 9% to 4,846,700 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-sinkule-joseph-acquired-400000-shares-increasing-direct-6214289)
- 2025-09-25 20:19 UTC [SEC Form 8-K] [Klotho Neurosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/klotho-neurosciences-inc-filed-sec-form-8-k-entry-into-a-6212011)
- 2025-09-25 20:15 UTC [SEC Form 8-K] [Klotho Neurosciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/klotho-neurosciences-inc-filed-sec-form-8-k-notice-of-delisting-6211984)
- 2025-09-08 12:00 UTC [Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar](https://www.quantisnow.com/insight/klotho-neurosciences-ceo-to-attend-inaugural-conference-scientific-seminar-6192576)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/KLTO
- Earnings history: https://www.quantisnow.com/earnings/KLTO
- Dividend history: https://www.quantisnow.com/dividends/KLTO
- Insider transactions: https://www.quantisnow.com/insiders/KLTO
- Options chain: https://www.quantisnow.com/options/KLTO
- SEC 8-K filings only: https://www.quantisnow.com/company/KLTO/8-k
- RSS and alerts for KLTO: https://www.quantisnow.com/docs/rss-feeds.md